Dr. Sridhara is director of the Division of Biometrics V in the Office of Biostatistics which supports the Office of Hematology Oncology Products in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration (FDA).
Dr. Sridhara has contributed to the understanding of statistical issues unique to the area of oncology disease such as evaluation and analysis of time to disease progression. Her research interests include evaluation of surrogate markers and design of clinical trials. She has organized, chaired and given invited presentations at several workshops, and has worked on regulatory guidance documents across multiple disciplines. She has published extensively in refereed journals and presented at national and international conferences. She is an elected fellow of the American Statistical Association.
Prior to joining FDA, Dr. Sridhara was a project statistician for the AIDS vaccine evaluation group at EMMES Corporation, and was an assistant professor at the University of Maryland Cancer Center.
